These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 25737447)
21. Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. Li Z; Wang Y; Yuan C; Zhu Y; Qiu J; Zhang W; Qi B; Wu H; Ye J; Jiang H; Yang J; Cheng J Lab Invest; 2014 Dec; 94(12):1431-45. PubMed ID: 25286028 [TBL] [Abstract][Full Text] [Related]
22. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug. Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261 [TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines. Contreras-Leal E; Hernández-Oliveras A; Flores-Peredo L; Zarain-Herzberg Á; Santiago-García J Mol Carcinog; 2016 Oct; 55(10):1477-85. PubMed ID: 26331238 [TBL] [Abstract][Full Text] [Related]
24. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Su SF; Chang YW; Andreu-Vieyra C; Fang JY; Yang Z; Han B; Lee AS; Liang G Oncogene; 2013 Sep; 32(39):4694-701. PubMed ID: 23085757 [TBL] [Abstract][Full Text] [Related]
25. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068 [TBL] [Abstract][Full Text] [Related]
26. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1. Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816 [TBL] [Abstract][Full Text] [Related]
27. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525 [TBL] [Abstract][Full Text] [Related]
28. Rapid alteration of microRNA levels by histone deacetylase inhibition. Scott GK; Mattie MD; Berger CE; Benz SC; Benz CC Cancer Res; 2006 Feb; 66(3):1277-81. PubMed ID: 16452179 [TBL] [Abstract][Full Text] [Related]
29. Breakdown of the FLT3-ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3-specific inhibitors. Pietschmann K; Bolck HA; Buchwald M; Spielberg S; Polzer H; Spiekermann K; Bug G; Heinzel T; Böhmer FD; Krämer OH Mol Cancer Ther; 2012 Nov; 11(11):2373-83. PubMed ID: 22942377 [TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging. Lee S; Jung JW; Park SB; Roh K; Lee SY; Kim JH; Kang SK; Kang KS Cell Mol Life Sci; 2011 Jan; 68(2):325-36. PubMed ID: 20652617 [TBL] [Abstract][Full Text] [Related]
31. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells. Weng JH; Yu CC; Lee YC; Lin CW; Chang WW; Kuo YL Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399693 [TBL] [Abstract][Full Text] [Related]
32. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Rao R; Balusu R; Fiskus W; Mudunuru U; Venkannagari S; Chauhan L; Smith JE; Hembruff SL; Ha K; Atadja P; Bhalla KN Mol Cancer Ther; 2012 Apr; 11(4):973-83. PubMed ID: 22367781 [TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells. Brazelle W; Kreahling JM; Gemmer J; Ma Y; Cress WD; Haura E; Altiok S PLoS One; 2010 Dec; 5(12):e14335. PubMed ID: 21179472 [TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells. Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786 [TBL] [Abstract][Full Text] [Related]
35. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1. Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660 [TBL] [Abstract][Full Text] [Related]
36. Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells. Yan-Fang T; Zhi-Heng L; Li-Xiao X; Fang F; Jun L; Gang L; Lan C; Na-Na W; Xiao-Juan D; Li-Chao S; Wen-Li Z; Pei-Fang X; He Z; Guang-Hao S; Yan-Hong L; Yi-Ping L; Yun-Yun X; Hui-Ting Z; Yi W; Mei-Fang J; Lin L; Jian N; Shao-Yan H; Xue-Ming Z; Xing F; Jian W; Jian P PLoS One; 2015; 10(7):e0126566. PubMed ID: 26176219 [TBL] [Abstract][Full Text] [Related]
37. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells. Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897 [TBL] [Abstract][Full Text] [Related]
38. TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells. Cao QF; Qian SB; Wang N; Zhang L; Wang WM; Shen HB Cancer Biother Radiopharm; 2015 Mar; 30(2):87-93. PubMed ID: 25760728 [TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma. Yang H; Lan P; Hou Z; Guan Y; Zhang J; Xu W; Tian Z; Zhang C Br J Cancer; 2015 Jan; 112(1):112-21. PubMed ID: 25393367 [TBL] [Abstract][Full Text] [Related]
40. Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6. Ando H; Miyamoto T; Kashima H; Higuchi S; Ida K; Mvunta DH; Shiozawa T Horm Cancer; 2017 Aug; 8(4):257-267. PubMed ID: 28516379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]